Cox John bought DYN
February 12, 2026 · Form 4 insider transaction
Cox John bought 180,000 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
180,000
Price
$0.00
Total value
N/A
InsiderCox John
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after376,877
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of shares of Common Stock issuable under 180,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on May 12, 2026.; Includes 288,976 unvested RSUs.